Daphne mucronata
Daphne mucronata · Accepted scientific name
Scientific literature: Very Sparse (1 studies) · ★☆☆☆☆
Daphne mucronata is a significant botanical species known for its diverse pharmacological potential. Recent scientific investigations have focused on the specific chemical profiles found within its tissues. Among these bioactive compounds, Gnidilatimonoein has emerged as a primary subject of study. This particular chemical is of great interest due to its documented antiproliferative activities. Understanding these mechanisms provides valuable insights into the plant's role in modern therapeutic research.
- Synonyms
- Daphne Angustifolia Var. Mucronata
- Common names
- Not available
- Family
- Thymelaeaceae
- Distribution
- Southern America
- Plant Parts
- Not available
Classification
Common Names
Daphne mucronata is a distinctive plant known by its Russian common name, Волчеягодник остроконечный. This species belongs to a genus celebrated for its fragrant blooms and intricate botanical characteristics. In many regions, its unique appearance and growth habits make it a notable subject for local naturalists. Understanding its regional nomenclature helps gardeners and researchers connect the plant to its specific cultural contexts. By recognizing both its scientific and common identities, one gains a deeper appreciation for this resilient shrub.
Sources: Catalogue of Life (COL)
Synonyms
Daphne mucronata is a plant species that is frequently identified by its various botanical classifications. In many scientific databases, it is recognized by the synonym Daphne angustifolia var. mucronata. This nomenclature variation can sometimes cause confusion for researchers and gardeners alike. Understanding these synonymous relationships is essential for ensuring accurate plant identification in the field. Maintaining clear taxonomic records helps bridge the gap between different naming conventions used across history.
Sources: The World Checklist of Vascular Plants (WCVP)
Taxonomy
Daphne mucronata is a distinctive species that belongs to the kingdom Plantae. Within this vast biological realm, it is classified under the class Equisetopsida. The plant is further organized into the order Malvales, showcasing its specific evolutionary placement. It is a member of the genus Daphne, which defines its primary botanical characteristics. Finally, this species is nested within the family Thymelaeaceae, completing its scientific classification.
| Rank | Classification |
|---|---|
| Kingdom | Plantae |
| Phylum | Streptophyta |
| Class | Equisetopsida |
| Subclass | Magnoliidae |
| Order | Malvales |
| Family | Thymelaeaceae |
| Genus | Daphne |
Sources: The World Checklist of Vascular Plants (WCVP)
Distribution
Geographic Regions
Daphne mucronata exhibits a broad and varied distribution across the Asia-Temperate region. This resilient species can be found spanning the rugged landscapes of the Arabian Peninsula, including specific populations in Oman and Saudi Arabia. Its presence further extends into the mountainous terrains of the Caucasus and Transcaucasus. Additionally, the plant is well-established throughout Western Asia, stretching through the territories of Afghanistan and Iran. This diverse geographical range highlights the plant's ability to adapt to various regional climates across the continent.
Sources: The World Checklist of Vascular Plants (WCVP)
Identification
Morphology
Daphne mucronata is a self-supporting plant characterized by its distinct shrub growth form. This species typically reaches a mature height ranging from a minimum of 2 meters to a maximum of 3 meters. Its sturdy structure allows it to maintain its shape within its natural habitat. Such consistent dimensions make it a reliable feature in various landscape designs.
Sources: Global Inventory of Floras and Traits (GIFT)
Biological Activities
Daphne mucronata has demonstrated significant antiproliferative activity through its isolated diterpene ester, gnidilatimonoein. Research indicates that this compound exhibits strong cytotoxicity against various human cancer cell lines, including leukemia and prostate cancer, as well as mouse fibrosarcoma. The mechanism of action involves inhibiting cell progression through the G1 phase and disrupting nucleic acid synthesis. Specifically, the compound primarily impacts DNA synthesis while also affecting RNA production to a lesser extent. These metabolic disruptions are largely attributed to the significant inhibition of the purine biosynthetic pathway within the treated cells.
Compounds
Daphne mucronata serves as a vital source of the diterpene ester known as gnidilatimonoein. Research has identified this specific compound as a highly active agent with significant antiproliferative properties against various human cancer cell lines. When applied to these cells, gnidilatimonoein effectively inhibits cell progression through the G1 phase of the cycle. The compound primarily exerts its metabolic influence by disrupting DNA and RNA synthesis within the targeted cancerous cells. Ultimately, these findings suggest that gnidilatimonoein holds great therapeutic potential due to its ability to significantly impact the purine biosynthetic pathway.
Conditions
Daphne mucronata, specifically through its active diterpene ester gnidilatimonoein, demonstrates strong antiproliferative activity against several human cancer cell lines. This plant extract effectively treats the CCRF-CEM, HL-60, and MOLT-4 leukemia cell lines. Furthermore, it has shown significant therapeutic potential in treating the K562 leukemia cell line, which appeared to be among the most responsive. The plant also provides treatment for the LNCaP-FGC-10 prostate cancer cell line. These medicinal effects are primarily driven by the inhibition of nucleic acid synthesis and the purine biosynthetic pathway.